Geron

layoffs downsizing job cuts staff cuts
Pharma

Geron plots deep layoffs in bid to curb operating costs

After winning an FDA nod decades in the making—and shuffling its executive roster throughout 2025—Geron Corporation is scaling back its head count.
Fraiser Kansteiner Dec 11, 2025 1:50pm
Graphic of an open door with the words exit above it

Geron losing commercial chief shortly after first FDA approval

Jul 24, 2024 4:34am
Marathon

FDA signs off on Geron's long-awaited blood cancer drug Rytelo

Jun 7, 2024 12:03pm
Food and Drug Administration

Geron hires a host of commercial, marketing execs

Jan 13, 2023 9:15am